|
Volumn 20, Issue 5, 2008, Pages 472-473
|
First-time use of bevacizumab for aggressive, metastatic hepatocellular carcinoma in an HIV/hepatitis B virus coinfected patient: A case report
|
Author keywords
Anti vascular endothelium growth factor; Bevacizumab; HIV hepatitis B virus coinfection; Metastatic hepatocellular carcinoma
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ASPARTATE AMINOTRANSFERASE;
BEVACIZUMAB;
BILIRUBIN;
DAUNORUBICIN;
FLUOROURACIL;
GAMMA GLUTAMYLTRANSFERASE;
LAMIVUDINE;
NEVIRAPINE;
SERUM ALBUMIN;
STAVUDINE;
TENOFOVIR;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALBUMIN BLOOD LEVEL;
ALCOHOL CONSUMPTION;
ALKALINE PHOSPHATASE BLOOD LEVEL;
AMINOTRANSFERASE BLOOD LEVEL;
ANAMNESIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CASE REPORT;
CD4 LYMPHOCYTE COUNT;
CLINICAL FEATURE;
DISEASE DURATION;
DRUG SUBSTITUTION;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
LIVER CELL CARCINOMA;
LIVER METASTASIS;
MALE;
MULTIPLE CYCLE TREATMENT;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
TUMOR BIOPSY;
VIRUS LOAD;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
FATAL OUTCOME;
HEPATITIS B, CHRONIC;
HIV INFECTIONS;
HIV-1;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
|
EID: 42149167957
PISSN: 0954691X
EISSN: None
Source Type: Journal
DOI: 10.1097/MEG.0b013e3282f16411 Document Type: Article |
Times cited : (6)
|
References (8)
|